CooperCompanies Q3 EPS $2.24 GAAP, $1.15 non-GAAP; completes strategic review, buyback to $3B

COOPER COMPANIES, INC.

Revenue $1.066B, +1% YoY; GAAP EPS $2.24 (incl. $307.2M tax benefit), non-GAAP EPS $1.15 (+4%).
Free cash flow $273M, +66% YoY; repurchased $339.1M of stock in Q3.
Strategic review complete: Board unanimously retains CooperSurgical; buyback authorization raised from $2B to $3B.
FY2026 guidance: revenue $4.229-4.252B, non-GAAP EPS $4.51-4.55; Q4 revenue $1.057-1.080B, non-GAAP EPS $1.05-1.09.
CooperVision revenue flat at $717M; CooperSurgical revenue $349.2M, +2% (organic +3%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.